DLB (DLB) investor details Rule 144 sale of 2,491 common shares
Rhea-AI Filing Summary
A notice under Rule 144 shows that shareholder Mark Andrew Sherman plans to sell 2,491 DLB common shares through Morgan Stanley Smith Barney on the NYSE. The planned sale has an aggregate market value of $167,553.88, with an approximate sale date of December 17, 2025. The issuer lists 60,845,846 common shares outstanding.
The 2,491 shares to be sold were acquired as restricted stock from the issuer on December 16, 2025. The notice also reports that Mark Andrew Sherman sold 9,109 common shares on December 16, 2025 for $607,849.03 and 4,500 shares on December 1, 2025 for $304,035.75. By signing, the seller represents that he is not aware of any material adverse information about the issuer’s operations that has not been publicly disclosed.
Positive
- None.
Negative
- None.
FAQ
What does the DLB Rule 144 notice disclose?
The notice shows that Mark Andrew Sherman plans to sell 2,491 DLB common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $167,553.88 and an approximate sale date of December 17, 2025.
How many DLB shares does Mark Andrew Sherman plan to sell and when?
He plans to sell 2,491 DLB common shares, with an approximate sale date listed as December 17, 2025.
How were the DLB shares in the planned sale acquired?
The 2,491 shares in the planned sale were acquired as restricted stock from the issuer on December 16, 2025, with the notice describing the nature of payment as Not Applicable.
What recent DLB stock sales by Mark Andrew Sherman are reported?
The notice reports that Mark Andrew Sherman sold 9,109 common shares on December 16, 2025 for $607,849.03 and 4,500 common shares on December 1, 2025 for $304,035.75.
How many DLB common shares are outstanding according to the notice?
The notice lists 60,845,846 DLB common shares outstanding in connection with the planned sale.
What representation does the seller make about material information on DLB?
By signing, the seller represents that he does not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.